Envisioning Health, Reimagined
Omar Khan, MD
Board-Certified Neurologist | Epileptologist | Clinical Neurophysiologist
Advanced Expertise. Academic Excellence. Compassionate Care.
Dr. Omar Khan is a highly trained neurologist and epileptologist with neurology training from Dartmouth and advanced fellowship training at the National Institutes of Health (NIH) and specialized board certifications in Neurology, Epilepsy, and Clinical Neurophysiology through the American Board of Psychiatry and Neurology (ABPN), along with advanced certification in epilepsy monitoring through the American Board of Clinical Neurophysiology (ABCN).
With extensive experience in complex neurological disorders, Dr. Khan specializes in the comprehensive evaluation and management of epilepsy, seizure disorders, and challenging neurological conditions. His expertise includes advanced EEG interpretation, long-term epilepsy monitoring, drug-resistant epilepsy, and the evaluation of patients for advanced therapeutic interventions, including epilepsy surgery and neuromodulation.
Beyond clinical practice, Dr. Khan has held significant leadership roles in neurological healthcare, including directing large-scale epilepsy programs, developing innovative telemedicine services, and advancing multidisciplinary approaches to neurological care. His work integrates clinical medicine, research, healthcare innovation, and the development of systems that improve access to specialized neurological expertise.
Dr. Khan believes that exceptional medical care requires more than advanced technology and scientific knowledge. It demands careful listening, thoughtful clinical judgment, and a genuine commitment to understanding each patient's unique challenges.
His philosophy reflects the central mission of The Brain Analysis Company: Bringing Compassion Back Into Healthcare.
State-of-the-Art Epilepsy Care
Advanced Diagnostics. Precision Treatment. Compassionate Care.
Epilepsy is a complex neurological disorder that requires more than simply controlling seizures. At The Brain Analysis Company, we bring together specialized clinical expertise, advanced diagnostic technologies, and the latest evidence-based treatments to provide comprehensive, individualized epilepsy care.
Our approach emphasizes accurate diagnosis, understanding the underlying causes of seizures, and developing personalized treatment strategies. Through detailed clinical evaluations, expert EEG interpretation, advanced neuroimaging, and precision medicine, we strive to identify the most effective treatment options for each patient.
For individuals with difficult-to-treat epilepsy, we explore advanced therapeutic approaches, including newer antiseizure medications, epilepsy surgery, and neuromodulation, collaborating with specialized centers when appropriate.
We recognize that epilepsy affects far more than seizure control. Our mission is to improve cognitive health, emotional well-being, independence, and quality of life—combining the best of modern neuroscience with our commitment to bringing compassion back into healthcare.
State-of-the-Art Cognitive and Dementia Care
Advanced Diagnostics. Precision Medicine. Compassionate Care.
Memory loss and cognitive changes can arise from a wide spectrum of neurological conditions, ranging from normal aging and mild cognitive impairment to Alzheimer's disease and other neurodegenerative disorders. At The Brain Analysis Company, we combine specialized neurological expertise, advanced diagnostic technologies, and evidence-based medicine to provide comprehensive, personalized cognitive care.
Our approach emphasizes early detection, accurate diagnosis, and a thorough understanding of the underlying causes of cognitive decline. Through detailed neurological evaluations, standardized cognitive assessments, advanced neuroimaging, laboratory investigations, and emerging biomarkers, we strive to distinguish between different causes of cognitive impairment and identify potentially reversible conditions.
Modern advances in dementia care are transforming how we diagnose and manage cognitive disorders. We incorporate the latest scientific evidence, including biomarker-guided diagnostics, emerging disease-modifying therapies, and individualized treatment strategies when clinically appropriate.
Recognizing that cognitive disorders affect not only patients but also their families, we emphasize multidisciplinary collaboration, caregiver education, cognitive rehabilitation, and long-term care planning. Our goal is not simply to diagnose disease, but to preserve independence, optimize cognitive function, and improve quality of life—bringing together the best of modern neuroscience with our commitment to bringing compassion back into healthcare.
